EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

MYCN Amplification Is Associated with Reduced Expression of Genes Encoding γ-Secretase Complex and NOTCH Signaling Components in Neuroblastoma

Prasoon Agarwal iD, Aleksandra Glowacka, Loay Mahmoud, Wesam Bazzar, Lars-Gunnar Larsson, Mohammad Alzrigat iD

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms24098141 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Prasoon Agarwal und 5 weiteren Autor:innen. Beteiligte Einrichtung: National Bioinformatics Infrastructure Sweden (NBIS), Science for Life Laboratory, Division of Occupational and Environmental Medicine, Department of…. Hauptthemen laut MEDLINE: Amyloid Precursor Protein Secretases, Neuroblastoma. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 104 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Barncancerfonden, OE och Edla Johanssons vetenskapliga stiftelse, Lillian Sagens och Curt Ericssons Forskningsstiftelse.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Amplification of the MYCN oncogene is found in ~20% of neuroblastoma (NB) cases and correlates with high-risk disease and poor prognosis. Despite the plethora of studies describing the role of MYCN in NB, the exact molecular mechanisms underlying MYCN’s contribution to high-risk disease are not completely understood. Herein, we implemented an integrative approach combining publicly available RNA-Seq and MYCN ChIP-Seq datasets derived from human NB cell lines to define biological processes directly regulated by MYCN in NB. Our approach revealed that MYCN-amplified NB cell lines, when compared to non-MYCN-amplified cell lines, are characterized by reduced expression of genes involved in NOTCH receptor processing, axoneme assembly, and membrane protein proteolysis. More specifically, we found genes encoding members of the γ-secretase complex, which is known for its ability to liberate several intracellular signaling molecules from membrane-bound proteins such as NOTCH receptors, to be down-regulated in MYCN-amplified NB cell lines. Analysis of MYCN ChIP-Seq data revealed an enrichment of MYCN binding at the transcription start sites of genes encoding γ-secretase complex subunits. Notably, using publicly available gene expression data from NB primary tumors, we revealed that the expression of γ-secretase subunits encoding genes and other components of the NOTCH signaling pathway was also reduced in MYCN-amplified tumors and correlated with worse overall survival in NB patients. Genetic or pharmacological depletion of MYCN in NB cell lines induced the expression of γ-secretase genes and NOTCH-target genes. Chemical inhibition of γ-secretase activity dampened the expression of NOTCH-target genes upon MYCN depletion in NB cells. In conclusion, this study defines a set of MYCN-regulated pathways that are specific to MYCN-amplified NB tumors, and it suggests a novel role for MYCN in the suppression of genes of the γ-secretase complex, with an impact on the NOTCH-target gene expression in MYCN-amplified NB.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Amyloid Precursor Protein SecretasesNeuroblastomaHumansSignal TransductionCell LineMembrane ProteinsN-Myc Proto-Oncogene ProteinGene Expression Regulation, NeoplasticCell Line, TumorGene Amplification

Stichwörter der Autor:innen

MYCNMYCN amplificationNOTCH signalingneuroblastomaγ-secretase

Substanzen

Amyloid Precursor Protein SecretasesMembrane ProteinsN-Myc Proto-Oncogene Protein

Autor:innen und Institutionen

  • National Bioinformatics Infrastructure Sweden (NBIS), Science for Life Laboratory, Division of Occupational and Environmental Medicine, Department of Laboratory Medicine, Lund University, 22362 Lund, Sweden.
  • Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, 17165 Solna, Sweden.
  • Department of Cell and Molecular Biology, Karolinska Institutet, 17177 Stockholm, Sweden.
  • Department of Pharmaceutical Biosciences, Biomedical Center, Uppsala University, 75124 Uppsala, Sweden.

ORCID-Profile: Prasoon Agarwal, Mohammad Alzrigat

Förderung

  • Barncancerfonden
  • OE och Edla Johanssons vetenskapliga stiftelse
  • Lillian Sagens och Curt Ericssons Forskningsstiftelse
  • Swedish Cancer Society
  • Novonordisk foundation
  • Swedish Childhood Cancer Society
  • Novo Nordisk Foundation
  • KI Foundations

Zitieren

APA

Agarwal, P., Glowacka, A., Mahmoud, L., Bazzar, W., Larsson, L. G., & Alzrigat, M. (2023). MYCN Amplification Is Associated with Reduced Expression of Genes Encoding γ-Secretase Complex and NOTCH Signaling Components in Neuroblastoma. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24098141

Vancouver

Agarwal P, Glowacka A, Mahmoud L, Bazzar W, Larsson LG, Alzrigat M. MYCN Amplification Is Associated with Reduced Expression of Genes Encoding γ-Secretase Complex and NOTCH Signaling Components in Neuroblastoma. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24098141

BibTeX
@article{Agarwal2023,
  author = {Agarwal, Prasoon and Glowacka, Aleksandra and Mahmoud, Loay and Bazzar, Wesam and Larsson, Lars-Gunnar and Alzrigat, Mohammad},
  title = {MYCN Amplification Is Associated with Reduced Expression of Genes Encoding γ-Secretase Complex and NOTCH Signaling Components in Neuroblastoma},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms24098141}
}
Kostenlos starten →